Skip to main content
. 2020 Dec 15;8(4):E877–E886. doi: 10.9778/cmajo.20200055

Table 4:

Pooled cumulative incidence and incidence difference per 1000 patients at 1 year for individual components of the primary and secondary outcomes

Outcome Group; 1-year cumulative incidence per 1000 patients (95% CI) Incidence difference (95% CI)
DOAC Warfarin
Ischemic stroke or systemic embolization 7.71 (5.67 to 9.75) 8.88 (5.22 to 12.54) −1.56 (−2.79 to −0.33)
Major bleeding 35.97 (23.60 to 48.34) 41.86 (21.23 to 62.49) −6.16 (−13.55 to 1.22)
Intracranial bleeding 2.84 (1.87 to 3.81) 4.10 (1.58 to 6.62) −1.25 (−2.32 to −0.17)
Gastrointestinal bleeding 19.00 (14.11 to 23.90) 15.49 (8.99 to 21.98) 1.08 (−0.72 to 2.88)
Myocardial infarction 7.50 (5.55 to 9.36) 7.40 (3.47 to 11.32) −0.29 (−1.42 to 0.83)
All-cause mortality 54.00 (37.91 to 70.09) 65.64 (47.16 to 84.12) −13.79 (−21.59 to −5.98)

Note: CI = confidence interval, DOAC = direct oral anticoagulant.